Background
• Although a number of studies were identified across different health-related behaviours and geographical regions, further research is needed to assess the feasibility and effectiveness of incentive-based interventions. For example, few studies compared the effectiveness of different types of intervention, or assessed whether improved outcomes were sustained in the long term (eg. >1 year).
• Studies investigating the cost-effectiveness of incentivebased interventions were not considered here; however, given the reliance on financial rewards as incentives and the potential long-term benefits of successful interventions to healthcare systems, such studies are required to assess the overall impact and feasibility of incentive-based interventions.
• To review the characteristics of recent and ongoing incentive-based trials, with a focus on incentives targeting behaviours in relation to lifestyle (diet, physical activity and weight management), HIV/AIDS-related behaviours and smoking cessation.
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• Positive changes in health-related behaviours may help to reduce the risk of illness and hence the burden of preventable disease.
Interventions that successfully promote healthier behaviours are therefore beneficial both for individuals and healthcare systems.
• Incentive-based interventions aim to improve health outcomes by rewarding individuals for specific health-related behaviours such as exercise, medication adherence or smoking cessation.
• To assess the feasibility and effectiveness of such interventions, incentive-based trials targeting a variety of health-related behaviours have been conducted across different geographical regions.
ClinicalTrials.gov Search
• A preliminary search of ClinicalTrials.gov was performed to scope currently active incentive-based trials. A targeted search was conducted, using the terms "incentive", "reward", "contingency", "prize", "reinforcement", "token", "voucher", "conditional cash transfer", "CCT", "pay for performance" or "P4P".
• Studies were of interest if they investigated the use of an incentive in modifying health-related behaviour (compared to either a different incentive or no incentive), and had the status "active, not recruiting".
• These studies were reviewed to identify the key topic areas in which incentive-based trials are conducted. Targeted searches were then conducted for these areas in PubMed.
PubMed Searches
• PubMed was searched for incentive-based trials published in the English language in the last 5 years, by combining terms for incentive-based trials with terms for the following topics:
-Diet, physical activity and weight management -HIV/AIDS-related behaviours, such as medication adherence or risk behaviours -Smoking cessation • Studies were selected for inclusion if they presented primary research conducted in humans, and investigated the effectiveness of incentives in modifying behaviour in relation to a topic area of interest.
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The type of incentive used was unclear for 12 (26.1%) studies in diet, physical activity and weight management, 2 (10.5%) studies in HIV/AIDS and 7 (12.5%) studies in smoking cessation. Study duration was unclear for 6 (13.0%) studies in diet, physical activity and weight management, 3 (15.8%) studies in HIV/AIDS and 13 (23.2%) studies in smoking cessation.
Examples of the behavioural changes studied • The relatively high prevalence of incentive-based trials in North America, particularly the USA, is likely a reflection of the particular public health problems and state of economic development in this region. The greater number of African-based trials in HIV/ AIDS-related behaviours relative to other target areas is likely to be reflective of the prevalence of HIV/AIDS in this region.
• Financial and voucher-based incentives were the most commonly used rewards across all target areas. It is possible that these may be particularly effective at targeting low-income groups, where financial barriers may exist to attaining improved health outcomes.
• The majority of the studies had a relatively short duration, with very few reporting outcomes for >1 year. As such, the evidence suggests that incentives may be effective in the short term, but there is a lack of evidence for their effectiveness over longer periods of time.
• Publication bias, in which positive trial results are more likely to be reported, may have inflated the proportion of included trials that reported successful incentive-based interventions. The reporting of negative trial results is important in order to avoid unnecessary expenditure in target areas where incentives are ineffective.
• Of the 1,492 PubMed search results, 121 met the pre-specified inclusion criteria: 46 were related to diet, physical activity and weight management, 19 were related to HIV/AIDS-related behaviours and 56 were related to smoking cessation.
• Examples of the positive behavioural changes assessed in each target area are presented in Table 1 .
• Of the 121 relevant studies, 85 (70.2%) were conducted in North America, 14 (11.6%) in Europe, 9 (7.4%) in Asia, 7 (5.8%) in Africa and 4 (3.3%) in Oceania (Figure 1 ). The locations for 2 of the studies were unclear.
-Of the incentive-based trials relating to diet, physical activity and weight management and smoking cessation, the majority were conducted in the USA (69.6% and 73.2%, respectively). -Almost one third of trials (31.6%) targeting HIV/AIDS-related behaviours were conducted in Africa.
• Overall, monetary incentives were the most commonly used type of incentive (44.6% of trials), with vouchers (19.8%) and lotteries/prize draws (7.4%) the second and third most common, respectively (Figure 2A ).
-This distribution was relatively consistent across the 3 different topic areas. However, food supplements were used as an incentive in 3 trials (15.8%) in HIV/AIDS, compared to no trials in diet, physical activity and weight management, or smoking cessationthese 3 trials were conducted in India and southern Africa.
• The length of time for which the effectiveness of incentives was assessed varied between studies, from days to years. Overall, the most common trial duration was 0-3 months (35.5%), with fewer trials lasting longer periods ( Figure 2B ).
-The most common trial duration in HIV/AIDS-related behaviour was >9-12 months, whereas shorter trials (0-3 months) were more frequently identified in the target area of smoking cessation.
• Incentive-based interventions were reported to improve outcomes in 87%, 58% and 82% of trials that targeted diet, physical activity and weight management, HIV/AIDS-related behaviours, and smoking cessation, respectively. (The effectiveness of incentives was considered 'not clear' or was not reported in 11%, 32% and 16% of trials in each target area of interest, respectively.) 
